Indian pharma needs to be receptive to the changes in pharmacopoeia standards which provide an independent assessment of quality, identity, strength and purity of therapeutics, said Rajeev Singh ...

Union Minister for Health and Family Welfare and Chemicals and Fertilizers, J. P. Nadda, today released the Indian Pharmacopoeia 2026 (IP 2026) - the 10th edition of India's official book of drug ...

New Delhi [India],January 2 (ANI): Union Minister for Health and Family Welfare and Chemicals and Fertilizers, J. P. Nadda, today released the Indian Pharmacopoeia 2026 (IP 2026) - the 10th edition of ...

In a bid to ensure quality, safety and efficacy of pharmaceutical products, the Indian Pharmacopoeia Commission (IPC) has added five new Indian Pharmacopoeial Reference Standards (IPRS) and seven new ...

New Delhi: India’s $50-billion pharmaceutical industry is set for a quality overhaul, as the government is preparing to unveil new safety and quality standards to reinforce the country’s reputation as ...

In April 2021, quality-control professionals from several Indian pharmaceutical firms attended a panel discussion on nitrosamine contamination in drugs. The firms, all of which supply to the US market ...